Concentrations of ethambutol in the cerebrospinal fluid after oral administration. 1971

J A Pilheu, and F Maglio, and R Cetrangolo, and A D Pleus

UI MeSH Term Description Entries
D004977 Ethambutol An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) Dexambutol,EMB-Fatol,EMB-Hefa,Etambutol Llorente,Ethambutol Hydrochloride,Etibi,Miambutol,Myambutol,EMB Fatol,EMB Hefa,Hydrochloride, Ethambutol,Llorente, Etambutol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014390 Tuberculosis, Meningeal A form of bacterial meningitis caused by MYCOBACTERIUM TUBERCULOSIS or rarely MYCOBACTERIUM BOVIS. The organism seeds the meninges and forms microtuberculomas which subsequently rupture. The clinical course tends to be subacute, with progressions occurring over a period of several days or longer. Headache and meningeal irritation may be followed by SEIZURES, cranial neuropathies, focal neurologic deficits, somnolence, and eventually COMA. The illness may occur in immunocompetent individuals or as an OPPORTUNISTIC INFECTION in the ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunodeficiency syndromes. (From Adams et al., Principles of Neurology, 6th ed, pp717-9) Meningitis, Tuberculous,TB Meningitis,Tubercular Meningitis,Tuberculosis Meningitis,Tuberculous Hypertrophic Pachymeningitis,Hypertrophic Pachymeningitides, Tuberculous,Hypertrophic Pachymeningitis, Tuberculous,Meningeal Tuberculoses,Meningeal Tuberculosis,Meningitides, Tubercular,Meningitides, Tuberculosis,Meningitides, Tuberculous,Meningitis, Tubercular,Meningitis, Tuberculosis,Pachymeningitides, Tuberculous Hypertrophic,Pachymeningitis, Tuberculous Hypertrophic,TB Meningitides,Tubercular Meningitides,Tuberculoses, Meningeal,Tuberculosis Meningitides,Tuberculous Hypertrophic Pachymeningitides,Tuberculous Meningitides,Tuberculous Meningitis

Related Publications

J A Pilheu, and F Maglio, and R Cetrangolo, and A D Pleus
May 1985, The New England journal of medicine,
J A Pilheu, and F Maglio, and R Cetrangolo, and A D Pleus
May 2015, Parkinsonism & related disorders,
J A Pilheu, and F Maglio, and R Cetrangolo, and A D Pleus
September 1974, Praxis der Pneumologie,
J A Pilheu, and F Maglio, and R Cetrangolo, and A D Pleus
March 1949, The Journal of laboratory and clinical medicine,
J A Pilheu, and F Maglio, and R Cetrangolo, and A D Pleus
January 1990, British journal of anaesthesia,
J A Pilheu, and F Maglio, and R Cetrangolo, and A D Pleus
January 1996, Journal of perinatology : official journal of the California Perinatal Association,
J A Pilheu, and F Maglio, and R Cetrangolo, and A D Pleus
March 1989, Anesthesia and analgesia,
J A Pilheu, and F Maglio, and R Cetrangolo, and A D Pleus
May 1997, Revue du rhumatisme (English ed.),
J A Pilheu, and F Maglio, and R Cetrangolo, and A D Pleus
January 1983, Sexually transmitted diseases,
J A Pilheu, and F Maglio, and R Cetrangolo, and A D Pleus
January 1972, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
Copied contents to your clipboard!